Symptoms daily cialis

pmid:29341503, doi:10.1111/luts.12144, meta-analysis, review, systematic review, yilin wang, yiping bao, yuanshan cui, erectile dysfunction / drug therapy*, humans, lower urinary tract symptoms / drug therapy*, lower urinary tract symptoms / etiology, male, phosphodiesterase 5 inhibitors / administration & dosage, phosphodiesterase 5 inhibitors / therapeutic use*, prostatic hyperplasia / complications, prostatic hyperplasia / drug therapy*, randomized controlled trials as topic, severity of illness index, tadalafil / administration & dosage, tadalafil / therapeutic use*, pubmed abstract, nih, nlm, ncbi, national institutes of health, national center for biotechnology information, national library of medicine, medline

Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis.
Objectives: We carried out a systematic review and meta-analysis to assess tadalafil 5 mg once-daily for the treatment of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED).
Methods: A literature review was performed to identify all published randomized double-blind, placebo-controlled trials of tadalafil 5 mg once-daily for the treatment of LUTS and ED. The search included the following databases: MEDLINE, EMBASE, and the Cochrane Controlled Trials Register. The reference lists of the retrieved studies were also investigated.
Conclusions: This meta-analysis indicates that tadalafil 5 mg once-daily to be an effective treatment for LUTS and ED with a low occurrence of side effects.
Keywords: erectile dysfunction; lower urinary tract symptoms; meta-analysis; randomized controlled trial; tadalafil.
Similar articles.
Porst H, Roehrborn CG, Secrest RJ, Esler A, Viktrup L. Porst H, et al. J Sex Med. 2013 Aug;10(8):2044-52. doi: 10.1111/jsm.12212. Epub 2013 Jun 19. J Sex Med. 2013. PMID: 23782459 Clinical Trial.
Kim SW, Park NC, Lee SW, Yang DY, Park JK, Moon DG, Yang SK, Lee SW, Moon KH, Ahn TY, Kim SW, Park K, Min KS, Ryu JK, Son H, Jung J, Hyun JS. Kim SW, et al. J Sex Med. 2017 Aug;14(8):1018-1027. doi: 10.1016/j.jsxm.2017.06.006. J Sex Med. 2017. PMID: 28760246 Clinical Trial.
Brock G, Broderick G, Roehrborn CG, Xu L, Wong D, Viktrup L. Brock G, et al. BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13. BJU Int. 2013. PMID: 23937669 Clinical Trial.
Carson CC, Rosenberg M, Kissel J, Wong DG. Carson CC, et al. Int J Clin Pract. 2014 Jan;68(1):94-103. doi: 10.1111/ijcp.12305. Int J Clin Pract. 2014. PMID: 24341303 Review.
Yan H, Zong H, Cui Y, Li N, Zhang Y. Yan H, et al. J Sex Med. 2014 Jun;11(6):1539-45. doi: 10.1111/jsm.12499. Epub 2014 Mar 13. J Sex Med. 2014. PMID: 24621088 Review.
Cited by.
Franco JVA, Tesolin P, Jung JH. Franco JVA, et al. Prostate Int. 2023 Mar;11(1):1-7. doi: 10.1016/j.prnil.2023.01.002. Epub 2023 Jan 10. Prostate Int. 2023. PMID: 36910900 Free PMC article. Review.
Yang CH, Ou YC, Lin CC, Lin YS, Tung MC, Yu CC, Lin JT, Wen CY. Yang CH, et al. Life (Basel). 2022 Jul 11;12(7):1029. doi: 10.3390/life12071029. Life (Basel). 2022. PMID: 35888117 Free PMC article. Review.
Goberdhan S, Blachman-Braun R, Nackeeran S, Masterson TA 3rd, Ramasamy R. Goberdhan S, et al. World J Urol. 2022 Jul;40(7):1799-1803. doi: 10.1007/s00345-022-04005-3. Epub 2022 Apr 25. World J Urol. 2022. PMID: 35469100 Free PMC article.
Kosilov K, Kuzina I, Kuznetsov V, Barabash O, Fedorishcheva E. Kosilov K, et al. Asian J Urol. 2022 Jan;9(1):42-50. doi: 10.1016/j.ajur.2021.04.002. Epub 2021 Apr 20. Asian J Urol. 2022. PMID: 35198395 Free PMC article.
Çakıcı ÖU, Dinçer S. Çakıcı ÖU, et al. Amino Acids. 2022 Jan;54(1):13-31. doi: 10.1007/s00726-021-03113-5. Epub 2021 Dec 1. Amino Acids. 2022. PMID: 34853916 Review.